TrialBone marrow transplantation2019
VCAP-AMP-VECP as a preferable induction chemotherapy in transplant-eligible patients with aggressive adult T-cell leukemia-lymphoma: a propensity score analysis.
Shigeo Fuji et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it